Home/ Supplements/ Ripped Juice Capsules

Ripped Juice Capsules

product on market Capsule Betancourt Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Ripped Juice Capsules
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Ripped Juice Proprietary Blend
527 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Dicalcium Phosphate Magnesium Stearate Silicon Dioxide Titanium Dioxide FD&C Red 40 FD&C Blue 1
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended dosage: As a dietary supplement, consume 1 capsule in between meals. Advanced users may consume 1 capsule in the morning and 1 capsule in the afternoon.

Warnings & Precautions

Do not take within 5 hours of sleep. Do not exceed 2 capsules within a 24 hour period.

Warning: Not intended for use by persons under the age of 18.

Do not exceed recommended dose.

Do not use if pregnant or nursing. Do not consume synephrine or caffeine from other sources, including but not limited to: Coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Do not use for more than 8 weeks.

Consult with your physician prior to use if you are taking medication, including but not limited to: MAO inhibitors, antidepressants, ibuprofen, aspirin, non steroidal anti-inflammatory drugs or products containing phenylephrine, ephedrine, pseudoephedrine, or other stimulants.

Consult your physician prior to use if you have a medical condition, including but not limited to: Heart, liver, kidney or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 4 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headaches or shortness of breath.

Formulation Notes

Thermogenic & nootropic activator

Fat Release 89% Cal Burn 278/day Waist To hip ratio

Metadata

Product Details

DSLD Entry Date2021-11-19
Product TypeOther Combinations
FormCapsule
DSLD ID262190
Data Updated2026-04-11
Research

Research Evidence

We're building the evidence profile for this product's ingredients. Check back soon.

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.